Literature DB >> 25491901

Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.

L Dröge1, I Herraìz, H Zeisler, D Schlembach, H Stepan, L Küssel, W Henrich, A Galindo, S Verlohren.   

Abstract

OBJECTIVE: In singleton pregnancies, soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF) and the sFlt-1/PlGF ratio have shown utility as a diagnostic test for pre-eclampsia (PE). The objective of this study was to characterize the maternal serum levels of sFlt-1, PlGF and sFlt-1/PlGF ratio in normal and pre-eclamptic twin pregnancies.
METHODS: In a European multicenter case-control study, 49 women with a twin pregnancy were enrolled, including 31 uneventful and 18 pre-eclamptic pregnancies. sFlt-1 and PlGF were measured and receiver-operating characteristics (ROC) analysis was performed. The median sFlt-1 and PlGF serum concentrations and sFlt-1/PlGF ratio were compared with those of a singleton cohort, matched for gestational age, with PE (n = 54) and with an uncomplicated pregnancy outcome (n = 238).
RESULTS: In twin pregnancies with PE, sFlt-1 levels and the sFlt-1/PlGF ratio were increased and PlGF levels were decreased as compared with those of twin gestations with an uneventful pregnancy outcome (20 011.50 ± 2330.35 pg/mL vs 4503.00 ± 2012.05 pg/mL (P ≤ 0.001), 164.22 ± 31.35 vs 13.29 ± 319.64 (P ≤ 0.001), and 138.80 ± 20.04 pg/mL vs 403.00 ± 193.10 pg/mL (P ≤ 0.001), respectively). The sFlt-1/PlGF ratio did not differ between twin pregnancies with PE and singleton pregnancies with PE. In twin pregnancies with an uneventful outcome, sFlt-1 levels and sFlt-1/PlGF ratio were increased, but no differences in PlGF concentration were found when compared with that of singleton controls. ROC analysis determined 53 as an optimal cut-off of the sFlt-1/PlGF ratio for diagnosing PE in twin gestations, yielding a sensitivity of 94.4% and a specificity of 74.2%. The cut-off values established for singleton pregnancies, of 33 and 85, led to sensitivities of 100% and 83.3%, and specificities of 67.7% and 80.6%, when used to detect PE in twin pregnancies.
CONCLUSIONS: Significant differences in the serum marker levels in singleton vs twin pregnancies were detected. Reference ranges of sFlt-1, PlGF and their ratio in singleton pregnancies are therefore not transferable to twin pregnancies.
Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  PlGF; angiogenic factors; multiple pregnancy; pre-eclampsia; sFlt-1; twins

Mesh:

Substances:

Year:  2015        PMID: 25491901     DOI: 10.1002/uog.14760

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  11 in total

Review 1.  Anti-angiogenesis and Preeclampsia in 2016.

Authors:  Susanne Schrey-Petersen; Holger Stepan
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

2.  Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.

Authors:  Carlos A Dias-Junior; Juanjuan Chen; Ning Cui; Charles L Chiang; Minglin Zhu; Zongli Ren; Jose S Possomato-Vieira; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2017-09-11       Impact factor: 5.858

3.  Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.

Authors:  Zongli Ren; Ning Cui; Minglin Zhu; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-03-23       Impact factor: 4.733

4.  Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice.

Authors:  Jacqueline G Parchem; Keizo Kanasaki; Megumi Kanasaki; Hikaru Sugimoto; Liang Xie; Yuki Hamano; Soo Bong Lee; Vincent H Gattone; Samuel Parry; Jerome F Strauss; Vesna D Garovic; Thomas F McElrath; Karen H Lu; Baha M Sibai; Valerie S LeBleu; Peter Carmeliet; Raghu Kalluri
Journal:  J Clin Invest       Date:  2018-10-08       Impact factor: 14.808

Review 5.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

6.  Successful management of twin pregnancy in a woman with advanced chronic kidney disease: A case report.

Authors:  Yunbo Wei; Yan Wang; Qiang Yao; Li Zhou; Ping Fu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 7.  Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia-A Systematic Review.

Authors:  Katarzyna Kosinska-Kaczynska; Magdalena Zgliczynska; Szymon Kozlowski; Lukasz Wicherek
Journal:  J Clin Med       Date:  2020-01-09       Impact factor: 4.241

Review 8.  Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration.

Authors:  Ignacio Herraiz; Elisa Simón; Paula Isabel Gómez-Arriaga; José Manuel Martínez-Moratalla; Antonio García-Burguillo; Elena Ana López Jiménez; Alberto Galindo
Journal:  Int J Mol Sci       Date:  2015-08-13       Impact factor: 5.923

9.  Evaluation of sFlt-1/PlGF Ratio for Predicting and Improving Clinical Management of Pre-eclampsia: Experience in a Specialized Perinatal Care Center.

Authors:  Hélène Caillon; Cécile Tardif; Erwan Dumontet; Norbert Winer; Damien Masson
Journal:  Ann Lab Med       Date:  2018-03       Impact factor: 3.464

Review 10.  Angiogenic factors: potential to change clinical practice in pre-eclampsia?

Authors:  A S Cerdeira; S Agrawal; A C Staff; C W Redman; M Vatish
Journal:  BJOG       Date:  2017-12-28       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.